Morgan Stanley: Lists Amazon (AMZN.O) as its top pick and raises its price target from $335 to $350, maintaining an "overweight" rating.

Key News 1. Pan Gongsheng: A liquidity support tool for large-scale redemptions by non-bank financial institutions will be launched; benchmark deposit and lending rates will be phased out and replaced by market-based interest rate indicators. 2. People's Bank of China (PBOC): Efforts will be made to provide financial support for the development of the artificial intelligence industry. 3. PBOC: Accelerate the implementation of reform measures for the Science and Technology Innovation Board (STAR Market) and improve the listing mechanism for technology companies. 4. China Securities Regulatory Commission (CSRC): Continuously enhance market resilience and confidence; fully safeguard the safety and stability of the capital market. 5. CSRC: Four measures will be launched soon to improve the rules for punishing illegal share reductions. 6. State Financial Regulatory Commission (SFC): Support more foreign institutions and long-term capital to operate in China. 7. CSRC publicly solicits opinions on the "Guiding Opinions on Advance Compensation in the Securities Market". 8. State Administration of Foreign Exchange (SAFE) plans to introduce a batch of incremental measures to support enterprises' participation in the international market. Individual Stock News 1. Shengyi Electronics: Plans to repurchase company shares worth 100 million to 200 million yuan. 2. Xiechuang Data: Xiechuang Intelligent Computing signed a computing power agreement of no more than 37.49 billion yuan. 3. Haiguang Information: Net profit increased by 45.12% year-on-year in the first three quarters. 4. Shanshui Technology: Net profit increased by 17.05% year-on-year in the third quarter, with the gross profit margin of dye intermediate products increasing compared to the same period last year. 5. Junya Technology: Q3 net profit increased by 620% quarter-on-quarter, with increased order value for PCB products. 6. Betta Pharmaceuticals: The Phase III clinical trial of a partner's voronib ophthalmic preparation failed to meet the primary endpoint; the company will conduct an impairment test on the voronib asset group. 7. Sanxia New Materials: Plans to acquire 100% equity of Zhuhai Saiwei, a lithium battery electrolyte company; stock resumes trading. 8. Jindu Shares: The company's low-altitude ducted propulsion business is still in the early stages of industrialization.

Iran's Persian Gulf Strait Management Authority says 122 vessels have been placed on its non-compliance list to date.